Ionis Pharmaceuticals, Inc.
MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION
Last updated:
Abstract:
Disclosed herein are antisense compounds and methods for decreasing HBV mRNA, DNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate HBV-related diseases, disorders or conditions.
Status:
Application
Type:
Utility
Filling date:
30 Jul 2021
Issue date:
3 Mar 2022